Rein Therapeutics Inc.

NASDAQ: RNTX · Real-Time Price · USD
1.24
0.08 (7.36%)
At close: Aug 15, 2025, 3:39 PM

Rein Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-5.61M -42.8M -6.07K -9.04K -7.21K -7.29K -1.98K -1.99K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-5.5M -42.41M -5.85K -8.94K -7.11K -7.34K -1.83K -1.79K
Net Income
-5.5M -40.98M -5.85K -8.94K -7.11K -7.34K -1.83K -1.79K
Selling & General & Admin
2.56M 2.48M 2.35K 5.3K 3.74K 5.33K 1.96K 1.89K
Research & Development
3.05M 3.32M 3.72K 3.74K 3.46K 1.97K 22.00 187.00
Other Expenses
n/a 37M n/a n/a n/a -12 6.00 -88
Operating Expenses
5.61M 42.8M 6.07K 9.04K 7.21K 7.29K 1.98K 1.99K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.61M 42.8M 6.07M 9.04K 7.21K 7.29K 1.98K 1.99K
Income Tax Expense
n/a -1.54M n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
2.19K 21.69K 21.66K 19.91K 8.3K 4.77K 4.54K 4.54K
Shares Outstanding (Diluted)
2.19K 21.69K 21.66K 19.91K 8.3K 4.77K 4.54K 4.54K
EPS (Basic)
-2.51K -1.89 -0.27 -0.45 -0.86 -1.54 -0.4 -0.39
EPS (Diluted)
-2.51K -1.89 -0.27 -0.45 -0.86 -1.54 -0.4 -0.39
EBITDA
-5.61M -5.8K -6.07K -9.04K -7.15K -7.25K -1.97K -2.07K
EBIT
-5.61M -5.8M -6.07K -9.04K -7.21K -7.3K -1.98K -2.08K
Depreciation & Amortization
n/a 5.79M n/a 4.00 59.00 52.00 12.00 12.00